Innovation, quality and service are the key criteria by which our solutions are measured. As specialists in osteosynthesis, we provide medical practitioners with top quality products to help them deliver better treatments to their patients.
As a competent partner in the field of traumatology and osteosynthesis, we maintain a constant dialogue with the people who use our products. In this way, we can make our contribution towards delivering new and ever better systems to achieve the best possible treatment outcomes.
Thanks to our in-house research, development and design departments we are able to respond to all challenges we are presented with and to use our capacity to innovate to keep pressing ahead with further improvements.
At Marquardt Medizintechnik, our Development, Design, Manufacturing, Quality Assurance and Sales departments all work together as one seamless unit. Our in-house manufacturing quota is almost 100 percent.
Above and beyond the applicable DIN and ASTM standards, Marquardt Medizintechnik has defined a range of specifications that are designed to ensure consistently high product quality.
As an independent family business, Marquardt Medizintechnik is a reliable partner who harnesses continuity and innovation in a unique way, combining stability with flexibility while bringing together the company's experience with fresh perspectives and a modern outlook. This will guarantee our ability to continue to produce top quality medical technology in Spaichingen in the future.
Our solutions for osteosynthesis are in demand all around the world. To ensure that our products are safe and effective within the scope of the relevant legislation that applies in each country, our customers have access to a contact person from Regulatory Affairs to help with enquiries.
Axomed is fully owned by Marquardt Medizintechnik since 2020. We operate as “Marquardt axomed GmbH” and continue with the usual security as a family-run company from Germany.
The expansion of the logistics hall and the administration area creates space for further growth.
Medid AG stands for customer-orientated direct sales of Marquardt implant systems in Switzerland. The merger will secure joint co-operation for the future.
First surgeries with the trans-sacral ISG Rod System.
Angle stable system for the fixation of arthrodeses of the ankle joint new in the portfolio.
axomed is now fully owned by Marquardt Medizintechnik. This merger offers a high degree of security for the future as a family-run company in Germany.
With a broad portfolio and complete solutions for osteosynthesis, we are ready for the next decade.
The family business welcomes Kim Marquardt and Timo Dietrich as additional members onto the executive board. They join forces with founder Dieter Marquardt, with whom they will lead the business into the future. This will ensure continuation of the company into the next generation.
The new fixed-angle complete system for fibula and tibia fractures is launched.
The packaging of sterile implants under clean room conditions is now also performed on site in Spaichingen. Regular qualifications and validated process monitoring ensure the high quality standard of Marquardt Medizintechnik.
The proximal humeral nail with patented blade support from Marquardt Medizintechnik new in the portfolio.
Marquardt UK is founded and takes over exclusive sales and distribution of Marquardt Medizintechnik products in the UK.
VITUS-PF, the first nail system from Marquardt Medizintechnik.
The sales company axomed is founded and takes over exclusive sales and distribution of Marquardt Medizintechnik products in the German-speaking region.
Marquardt Medizintechnik launches its first fixed-angle anatomical plate system.
The company Marquardt Medizintechnik opens its new company headquarters in Spaichingen with a production hall and administration offices.
The company Marquardt Medizintechnik is founded by Dieter Marquardt.